The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Triage of HPV positive women in cervical cancer screening
Open accessAbstract
Despite HPV vaccines, screening will remain central for decades to control cervical cancer. Recently, HPV testing alone or with cytology was introduced as an alternative to cytology screening. However, most HPV infections are harmless and additional tests are required to identify women with progressing infections or precancer. With three options for primary screening, and without clear strategies for triage of screen-positive women, there is great confusion about the best approach. Also, increasing HPV vaccination coverage will lead to lower disease prevalence, and force new screening approaches. Currently recommended triage strategies for primary HPV screening include HPV genotyping for HPV16 and HPV18 and cytology. Other alternatives that are currently evaluated include p16/Ki-67 dual stain cytology, host methylation, and viral methylation testing. Clinical management of women with cervical cancer screening results is moving to use risk thresholds rather than individual test results. Specific risk thresholds have been defined for return to primary screening, repeat testing, referral to colposcopy, and immediate treatment. Choice of test algorithms is based on comparison of absolute risk estimates from triage tests with established clinical thresholds. Importantly, triage tests need to be evaluated together with the primary screening test and the downstream clinical management. An optimal integrated screening and triage strategy should reassure the vast majority of women that they are at very low risk of cervical cancer, send the women at highest risk to colposcopy at the right time, when disease can be colposcopically detected, and minimize the intermediate risk group that requires continued surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Self-citationde Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Self-citationThe Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,144
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,123
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Self-citationEvidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Self-citationArbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 760
Self-citationHuman Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Self-citationMassad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W. K., Schiffman, M., Solomon, D., Wentzensen, N., & Lawson, H. W. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318287d329 · Cited by 730
Self-citationArbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674
Self-citationLăără, E., Day, N., & Hakama, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92695-x · Cited by 657
Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., & Wright, T. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.11.076 · Cited by 592
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00418-6 · Cited by 562
Castle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 523
2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181585870 · Cited by 354
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.462 · Cited by 321
Trends of cervical cancer mortality in the member states of the European Union
Arbyn, M., Raifu, A. O., Weiderpass, E., Bray, F., & Anttila, A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.018 · Cited by 298
Self-citationWhich high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Arbyn, M., Snijders, P. J. F., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Kocjan, B. J., & Poljak, M. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.015 · Cited by 275
Self-citationKinney, W. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00080-5 · Cited by 274
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00413-7 · Cited by 267
Gage, J. C., Schiffman, M., Katki, H. A., Castle, P. E., Fetterman, B., Wentzensen, N., Poitras, N. E., Lorey, T., Cheung, L. C., & Kinney, W. K. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju153 · Cited by 258
Self-citationvon Karsa, L., Arbyn, M., De Vuyst, H., Dillner, J., Dillner, L., Franceschi, S., Patnick, J., Ronco, G., Segnan, N., Suonio, E., et al. (2015) · Papillomavirus Research · doi:10.1016/j.pvr.2015.06.006 · Cited by 253
Self-citationWentzensen, N., Schwartz, L., Zuna, R. E., Smith, K., Mathews, C., Gold, M. A., Allen, R. A., Zhang, R., Dunn, S. T., Walker, J. L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0270 · Cited by 247
Self-citationReducing HPV-Associated Cancer Globally
Lowy, D. R., & Schiller, J. T. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0542 · Cited by 238
Petry, K. U., Schmidt, D., Scherbring, S., Luyten, A., Reinecke-Lüthge, A., Bergeron, C., Kommoss, F., Löning, T., Ordi, J., Regauer, S., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.02.033 · Cited by 226
Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy
Wentzensen, N., Walker, J. L., Gold, M. A., Smith, K. M., Zuna, R. E., Mathews, C., Dunn, S. T., Zhang, R., Moxley, K., Bishop, E., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9948 · Cited by 225
Self-citationKatki, H. A., Schiffman, M., Castle, P. E., Fetterman, B., Poitras, N. E., Lorey, T., Cheung, L. C., Raine-Bennett, T., Gage, J. C., & Kinney, W. K. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318285423c · Cited by 212
Self-citationp16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
Wentzensen, N., Fetterman, B., Castle, P. E., Schiffman, M., Wood, S. N., Stiemerling, E., Tokugawa, D., Bodelon, C., Poitras, N., Lorey, T., et al. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv257 · Cited by 191
Self-citationHuman Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer
Clarke, M. A., Wentzensen, N., Mirabello, L., Ghosh, A., Wacholder, S., Harari, A., Lorincz, A., Schiffman, M., & Burk, R. D. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0905 · Cited by 183
Self-citationCarozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Gillio-Tos, A., De Marco, L., Giorgi-Rossi, P., Pontenani, G., Rosso, S., Sani, C., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70208-0 · Cited by 181
Risk assessment to guide the prevention of cervical cancer
Castle, P. E., Sideri, M., Jeronimo, J., Solomon, D., & Schiffman, M. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.049 · Cited by 179
Self-citationVerhoef, V. M. J., Bosgraaf, R. P., van Kemenade, F. J., Rozendaal, L., Heideman, D. A. M., Hesselink, A. T., Bekkers, R. L. M., Steenbergen, R. D. M., Massuger, L. F. A. G., Melchers, W. J. G., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70019-1 · Cited by 177
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions
Arbyn, M., Roelens, J., Simoens, C., Buntinx, F., Paraskevaidis, E. A., Martin‐Hirsch, P. L., & Prendiville, W. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008054.pub2 · Cited by 161
Self-citationMethylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3
Wentzensen, N., Sun, C., Ghosh, A., Kinney, W., Mirabello, L., Wacholder, S., Shaber, R., LaMere, B., Clarke, M., Lorincz, A. T., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs425 · Cited by 160
Self-citationHuman Papillomavirus and Cervical Cancer: Biomarkers for Improved Prevention Efforts
Sahasrabuddhe, V. V., Luhn, P., & Wentzensen, N. (2011) · Future Microbiology · doi:10.2217/fmb.11.87 · Cited by 155
Self-citationSCHIFFMAN, M. H., Glass, A. G., Wentzensen, N., Rush, B. B., Castle, P. E., Scott, D. R., Buckland, J., Sherman, M. E., Rydzak, G., Kirk, P., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0206 · Cited by 152
Self-citationCarozzi, F., Gillio‐Tos, A., Confortini, M., Mistro, A. D., Sani, C., Marco, L. D., Girlando, S., Rosso, S., Naldoni, C., Palma, P., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70529-6 · Cited by 149
Arbyn, M., Roelens, J., Cuschieri, K. S., Cuzick, J. M., Szarewski, A., Ratnam, S., Reuschenbach, M., Belinson, S., Belinson, J. L., & Monsonégo, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27636 · Cited by 138
Self-citationStrooper, L. M. A. D., Meijer, C. J. L. M., Berkhof, J. H., Hesselink, A. T., Snijders, P. J. F., Steenbergen, R. D. M., & Heideman, D. A. M. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0237 · Cited by 137
Mirabello, L. J., Sun, C., Ghosh, A., Rodríguez, A. C., SCHIFFMAN, M. H., Wentzensen, N., Hildesheim, A., Herrero, R., Wacholder, S., Lorincz, A. T., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs135 · Cited by 132
Self-citationBergeron, C., Ronco, G., Reuschenbach, M., Wentzensen, N., Arbyn, M., Stoler, M. H., & Doeberitz, M. V. K. (2014) · International Journal of Cancer · doi:10.1002/ijc.28900 · Cited by 128
Self-citationBierkens, M., Hesselink, A. T., Meijer, C. J. L. M., Heideman, D. A. M., Wisman, G. B. A., van der Zee, A. G. J., Snijders, P. J. F., & Steenbergen, R. D. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28138 · Cited by 117
An Evaluation of Novel, Lower-Cost Molecular Screening Tests for Human Papillomavirus in Rural China
Zhao, F., Jerónimo, J., Qiao, Y., Schweizer, J., Chen, W., Valdez, M., Lu, P. S., Zhang, X., Kang, L.-N., Bansil, P., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0091 · Cited by 115
Einstein, M. H., Martens, M. G., García, F., Ferris, D. G., Mitchell, A. L., Day, S. P., & Olson, M. C. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.04.013 · Cited by 114
Strooper, L. M. A. D., van Zummeren, M., Steenbergen, R. D. M., Bleeker, M. C. G., Hesselink, A. T., Wisman, G. B. A., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202616 · Cited by 109
How to evaluate emerging technologies in cervical cancer screening?
Arbyn, M., Ronco, G., Cuzick, J. M., Wentzensen, N., & Castle, P. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24774 · Cited by 108
Self-citationCervical cancer screening: on the way to a shift from cytology to full molecular screening
Dijkstra, M. G., Snijders, P. J. F., Arbyn, M., Rijkaart, D., Berkhof, J. H., & Meijer, C. J. L. M. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt538 · Cited by 104
Self-citationEinstein, M. H., Smith, K., Davis, T. E., Schmeler, K. M., Ferris, D. G., Savage, A. H., Gray, J. E., Stoler, M. H., Wright, T. C., Ferenczy, A. S., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00176-14 · Cited by 99
Risk Assessment to Guide the Prevention of Cervical Cancer
Castle, P. E., Sideri, M. G., Jerónimo, J., Solomon, D., & SCHIFFMAN, M. H. (2008) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31815ea58b · Cited by 99
Self-citationVasiljević, N., Scibior‐Bentkowska, D., Brentnall, A. R., Cuzick, J. M., & Lorincz, A. T. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.02.001 · Cited by 97
Iftner, T., Becker, S., Neis, K.-J., Castañón, A., Iftner, A., Holz, B., Staebler, A., Henes, M., Rall, K., Haedicke, J., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01013-15 · Cited by 96
Lower cost strategies for triage of human papillomavirus DNA‐positive women
Qiao, Y., Jerónimo, J., Zhao, F., Schweizer, J., Chen, W., Valdez, M., Lu, P. S., Zhang, X., Kang, L., Bansil, P., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28616 · Cited by 94
Dijkstra, M. G., van Niekerk, D., Rijkaart, D., van Kemenade, F. J., Heideman, D. A. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0173 · Cited by 92
Bergeron, C., Rossi, P. G., Cas, F., Schiboni, M. L., Ghiringhello, B., Palma, P. D., Minucci, D., Rosso, S., Zorzi, M., Naldoni, C., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju423 · Cited by 87
on behalf of the NHSCSP HPV Special Interest Group, Kelly, R. S., Patnick, J., Kitchener, H. C., & Moss, S. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.326 · Cited by 82
Richardson, L., El‐Zein, M., Ramanakumar, A. V., Ratnam, S., Sangwa‐Lugoma, G., Longatto‐Filho, A., Cardoso, M. A., Coutlée, F., & Franco, E. L. (2015) · Cancer Cytopathology · doi:10.1002/cncy.21596 · Cited by 58
Hesselink, A. T., Meijer, C. J. L. M., Poljak, M., Berkhof, J. H., van Kemenade, F. J., van der Salm, M. L., Bogaarts, M., Snijders, P. J. F., & Heideman, D. A. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00633-13 · Cited by 57
Wright, T. C., Stoler, M. H., Agreda, P. M., Beitman, G. H., Gutierrez, E. C., Harris, J. M., Koch, K. R., Kuebler, M., LaViers, W. D., Legendre, B. L., et al. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcp53kmhnrdicbl · Cited by 47
Semantic Focusing Allows Fully Automated Single-Layer Slide Scanning of Cervical Cytology Slides
Lahrmann, B., Valous, N. A., Eisenmann, U., Wentzensen, N., & Grabe, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061441 · Cited by 42
Self-citationAllìa, E., Ronco, G., Coccia, A., Luparia, P., Macrì, L., Fiorito, C., Maletta, F., Deambrogio, C., Tùnesi, S., Marco, L. D., et al. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21511 · Cited by 41
Cervical Cytology Biobanks as a Resource for Molecular Epidemiology
Arbyn, M., Andersson, K., Bergeron, C., Bogers, J.-P., von Knebel-Doebertitz, M., & Dillner, J. (2010) · Methods in molecular biology · doi:10.1007/978-1-59745-423-0_15 · Cited by 35
Self-citationCastle, P. E., Cuzick, J. M., Stoler, M. H., Wright, T. C., Reid, J. L., Dockter, J., Giachetti, C., & Getman, D. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcplcd8ttomljtb · Cited by 34
Alaghehbandan, R., Fontaine, D., Bentley, J., Escott, N. G., Ghatage, P., Lear, A., Coutlée, F., & Ratnam, S. (2013) · Diagnostic Cytopathology · doi:10.1002/dc.22944 · Cited by 29
Luhn, P., Houldsworth, J., Cahill, L. M., Schiffman, M., Castle, P. E., Zuna, R. E., Dunn, S. T., Gold, M. A., Walker, J. L., & Wentzensen, N. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.06.005 · Cited by 28
Self-citationUse of HC2 to triage women with borderline and mild dyskaryosis in the UK
Arbyn, M., Roelens, J., Martin‐Hirsch, P. L., Leeson, S. C., & Wentzensen, N. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.351 · Cited by 26
Self-citationFilling a gap in cervical cancer screening programmes
Wentzensen, N., & SCHIFFMAN, M. H. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70073-7 · Cited by 21
Self-citationStampler, K. M., & Dunton, C. J. (2010) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181bbb62e · Cited by 7
Cited by
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationHuman papillomavirus vaccine against cervical cancer: Opportunity and challenge
Wang, R., Pan, W., Jin, L., Huang, W., Li, Y., Wu, D., Gao, C., Ma, D., & Liao, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.039 · Cited by 493
The IARC Perspective on Cervical Cancer Screening
Bouvard, V., Wentzensen, N., Mackie, A., Berkhof, J., Brotherton, J., Giorgi-Rossi, P., Kupets, R., Smith, R., Arrossi, S., Bendahhou, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmsr2030640 · Cited by 357
Self-citationHu, Z., & Ma, D. (2018) · Cancer Medicine · doi:10.1002/cam4.1501 · Cited by 338
International Anal Neoplasia Society's consensus guidelines for anal cancer screening
Stier, E. A., Clarke, M. A., Deshmukh, A. A., Wentzensen, N., Liu, Y., Poynten, I. M., Cavallari, E. N., Fink, V., Barroso, L. F., Clifford, G. M., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34850 · Cited by 310
Self-citation
Metadata
- Authors
- Wentzensen, N., Schiffman, M., Palmer, T., & Arbyn, M.
- Venue
- Journal of Clinical Virology
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 76
- Pages
- S49-S55
- ISSN
- 1386-6532 (ISSN-L)
- OpenAlex
- W2172748090
- Cited by
- 347
- References
- 70
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.